NEWPORT NEWS, Va., and SAN DIEGO, Dec. 2 /PRNewswire/ -- The Patient Advocate Foundation (PAF), with support from ImpediMed Ltd. (ASX: IPD), is pleased to announce the launch of the Lymphedema CareLine (LCL). PAF, through its MedCare Division, is offering the national, toll-free patient/provider hotline designed to provide information and assistance to breast cancer patients who are or may be at risk for post-treatment side effects such as lymphedema (swelling due to blockage in the lymphatic system).
Staffed by a dedicated team of multilingual clinical case managers with nursing and social work experience, the LCL offers personal case management services, including the dissemination of information about lymphedema, navigation through the reimbursement system, interpretation of a patients' health insurance benefit language, provision of direct appeals assistance and linkage to appropriate educational and support resources. The hotline can be accessed at (866) 949-1978 or on the Web at LCL.patientadvocate.org.
The LCL is the latest addition to PAF's portfolio of patient services, which include direct case management services; the National Hispanic/Latino, African American and Senior Outreach initiatives; Hematologic Cancer Education Program; ACS/PAF Partnership Program and the national Lance Armstrong Foundation Livestrong SurvivorCare partnership.
"While better treatment and earlier detection of breast cancer has extended survival rates, lymphedema remains a significant risk to a woman's quality of life," said John Ennis, Co-Founder, Chief Development Officer at PAF. "We are encouraged to know that ImpediMed's technology can aid doctors in the pre-operative clinical assessment and ongoing surveillance of patients to help manage this impairment in newly diagnosed breast cancer patients and women at risk."
Beth Darnley, Chief Program Officer at PAF, added, "Navigating the
|SOURCE ImpediMed Ltd.|
Copyright©2008 PR Newswire.
All rights reserved